entertainment -WSS

entertainment

author：explore 2025-10-01 04:13:41 - browse：351

An Ozempic pen connects dots that make up the shape o a brain — coverage from STAT — ILLUSTRATION: CHRISTINE KAO/STAT; PHOTOS: ADOBE

Drugs like Ozempic and Wegovy — already game changers for diabetes and obesity — are being studied to treat an entirely different growing health problem: mental health illnesses, including depression and bipolar disorder.

Early data and anecdotes suggest that this class of GLP-1 drugs could help patients feel less depressed and anxious. The treatment may also fight the decline in cognitive and executive function that many people with mental health disorders experience, like worsening memory and losing the ability to focus and plan.

If further research yields positive results, it could drive even more demand for the highly popular GLP-1 treatments, which have increasingly been shown to help with problems across the body, such as heart and kidney complications. And especially if the cognitive benefits are proven out, the GLP-1 drugs would plug a critical gap in current treatments for depression, since most depression drugs help with mood, but close to none address cognitive symptoms that affect memory and attention.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Susan Tousi leaves Illumina to head cancer liquid biopsy startup

WSS

Maui wildfire now ranks as the fifth

BMS, looking to build heart drug business, turns to AI for diagnosis

Treatments for cramps don't cut it. Why aren't there better options?

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

3 medical device trends to watch in 2024

AdventHealth escalates lawsuit against insurance vendor Multiplan

focus

entertainment

focus

Medicare details structure of new drug price negotiation program

White House finalizes ITC's import ban of latest Apple Watches

State Dept. review finds Biden bears some blame for Afghanistan failures

The biotech scorecard for Q1: 17 stock

Supreme Court strikes down use of affirmative action

What to know about the judge who will handle the Trump case

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Schizophrenia gene found to be linked to cells' energy dysfunction

Alkermes shareholders re

J&J to buy cancer drug developer Ambrx Biopharma

knowledge

Hospitals are dialing back on venture capital investing

Patients, digital health players weigh in on FTC's data privacy plan

Goldman Sachs launches $650M fund for life science investments

Aspartame and sugar

Federal weight loss drug coverage is 30 years out of date

Megan Rapinoe shares emotional post following US Women's World Cup exit

focus

entertainment

Wikipedia

leisure time